130 related articles for article (PubMed ID: 17550757)
1. Temozolomide-associated organizing pneumonitis.
Maldonado F; Limper AH; Lim KG; Aubrey MC
Mayo Clin Proc; 2007 Jun; 82(6):771-3. PubMed ID: 17550757
[TBL] [Abstract][Full Text] [Related]
2. Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.
Ganière V; Christen G; Bally F; Guillou L; Pica A; de Ribaupierre S; Stupp R
Nat Clin Pract Oncol; 2006 Jun; 3(6):339-43; quiz following 343. PubMed ID: 16757971
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide.
Gorospe Sarasúa L; Ureña-Vacas A; Muñoz Del Toro JR
Arch Bronconeumol; 2016 Oct; 52(10):534-5. PubMed ID: 27021139
[No Abstract] [Full Text] [Related]
4. Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia.
Yu SK; Chalmers AJ
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):631-2. PubMed ID: 17644327
[No Abstract] [Full Text] [Related]
5. A fatal case of acute interstitial pneumonia (AIP) in a woman affected by glioblastoma.
Balzarini L; Mancini C; Marvisi M
Curr Drug Saf; 2014 Mar; 9(1):73-6. PubMed ID: 24410308
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.
De Vos FY; Gijtenbeek JM; Bleeker-Rovers CP; van Herpen CM
Crit Rev Oncol Hematol; 2013 Mar; 85(3):373-82. PubMed ID: 22925496
[TBL] [Abstract][Full Text] [Related]
7. [Temozolomide, an oral chemotherapeutic agent with potential severe toxicity].
Soetekouw PM; Gijtenbeek JM; van der Maazen RW; Kappelle AC; van Herpen CM
Ned Tijdschr Geneeskd; 2007 Jan; 151(4):253-7. PubMed ID: 17323884
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis.
Neuwelt AJ; Nguyen TM; Fu R; Bubalo J; Tyson RM; Lacy C; Gahramanov S; Nasseri M; Barnes PD; Neuwelt EA
CNS Oncol; 2014 Jul; 3(4):267-73. PubMed ID: 25286038
[TBL] [Abstract][Full Text] [Related]
9. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
Tan CW; See SJ; Tham CK; Ang AL
Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145
[No Abstract] [Full Text] [Related]
10. Temozolomide-associated bronchiolitis obliterans organizing pneumonia successfully treated with high-dose corticosteroid.
Kim TO; Oh IJ; Kang HW; Chi SY; Ban HJ; Kwon YS; Kim KS; Kim YI; Lim SC; Kim YC
J Korean Med Sci; 2012 Apr; 27(4):450-3. PubMed ID: 22468112
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
Chou KN; Lin YC; Liu MY; Chang PY
J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
[TBL] [Abstract][Full Text] [Related]
13. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
Stupp R; Dietrich PY; Ostermann Kraljevic S; Pica A; Maillard I; Maeder P; Meuli R; Janzer R; Pizzolato G; Miralbell R; Porchet F; Regli L; de Tribolet N; Mirimanoff RO; Leyvraz S
J Clin Oncol; 2002 Mar; 20(5):1375-82. PubMed ID: 11870182
[TBL] [Abstract][Full Text] [Related]
14. Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology?
Binello E; Germano IM
J Neurooncol; 2009 Aug; 94(1):145-8. PubMed ID: 19199004
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
[TBL] [Abstract][Full Text] [Related]
16. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
Meije Y; Lizasoain M; García-Reyne A; Martínez P; Rodríguez V; López-Medrano F; Juan RS; Lalueza A; Aguado JM
Clin Infect Dis; 2010 Jun; 50(12):e73-6. PubMed ID: 20455691
[TBL] [Abstract][Full Text] [Related]
17. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
[TBL] [Abstract][Full Text] [Related]
18. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma.
Yaman E; Coskun U; Ozturk B; Buyukberber S; Kaya AO; Coskun O; Buyukberber N; Yildiz R; Benekli M
J Clin Neurosci; 2009 Apr; 16(4):591-2. PubMed ID: 19201195
[TBL] [Abstract][Full Text] [Related]
19. Urticarial hypersensitivity reaction caused by temozolomide.
Pothiawala S; Hsu MY; Yang C; Kesari S; Ibrahimi OA
J Drugs Dermatol; 2010 Sep; 9(9):1142-4. PubMed ID: 20865848
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide (Temodar).
Wesolowski JR; Rajdev P; Mukherji SK
AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
